Lu W - Search Results

1

The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.

Mei D, Lin Z, Fu J, He B, Gao W, Ma L, Dai W, Zhang H, Wang X, Wang J, Zhang X, Lu W, Zhou D, Zhang Q. Mei D, et al. Among authors: lu w. Biomaterials. 2015 Feb;42:52-65. doi: 10.1016/j.biomaterials.2014.11.044. Epub 2014 Dec 13. Biomaterials. 2015. PMID: 25542793

2

In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.

Chen DB, Yang TZ, Lu WL, Zhang Q. Chen DB, et al. Among authors: lu wl. Chem Pharm Bull (Tokyo). 2001 Nov;49(11):1444-7. doi: 10.1248/cpb.49.1444. Chem Pharm Bull (Tokyo). 2001. PMID: 11724235 Free article.

3

Total coenzyme Q10 concentrations in Asian men following multiple oral 50-mg doses administered as coenzyme Q10 sustained release tablets or regular tablets.

Lu WL, Zhang Q, Lee HS, Zhou TY, Sun HD, Zhang DW, Zheng L, Lee M, Wong SM. Lu WL, et al. Biol Pharm Bull. 2003 Jan;26(1):52-5. doi: 10.1248/bpb.26.52. Biol Pharm Bull. 2003. PMID: 12520172 Free article. Clinical Trial.

4

A pegylated liposomal platform: pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug.

Lu WL, Qi XR, Zhang Q, Li RY, Wang GL, Zhang RJ, Wei SL. Lu WL, et al. J Pharmacol Sci. 2004 Jul;95(3):381-9. doi: 10.1254/jphs.fpj04001x. J Pharmacol Sci. 2004. PMID: 15272215 Free article.

5

Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.

Yu S, Zhao Y, Wu F, Zhang X, Lü W, Zhang H, Zhang Q. Yu S, et al. Among authors: lu w. Int J Pharm. 2004 Aug 20;281(1-2):11-23. doi: 10.1016/j.ijpharm.2004.05.007. Int J Pharm. 2004. PMID: 15288339

6

Antipyretic, analgesic and anti-inflammatory activities of ketoprofen beta-cyclodextrin inclusion complexes in animals.

Lu WL, Zhang Q, Zheng L, Wang H, Li RY, Zhang LF, Shen WB, Tu XD. Lu WL, et al. Biol Pharm Bull. 2004 Oct;27(10):1515-20. doi: 10.1248/bpb.27.1515. Biol Pharm Bull. 2004. PMID: 15467187 Free article.

7

Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.

Liu Y, Lu WL, Zhang X, Wang XQ, Zhang H, Zhang Q. Liu Y, et al. Peptides. 2005 Mar;26(3):423-30. doi: 10.1016/j.peptides.2004.10.003. Peptides. 2005. PMID: 15652649

8

In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.

Ke GM, Wang L, Xue HY, Lu WL, Zhang X, Zhang Q, Guo HY. Ke GM, et al. Biol Pharm Bull. 2005 Feb;28(2):305-10. doi: 10.1248/bpb.28.305. Biol Pharm Bull. 2005. PMID: 15684489 Free article.

9

[Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].

Dai JD, Wang XQ, Zhang T, Meng M, Zhang X, Lü WL, Zhang Q. Dai JD, et al. Yao Xue Xue Bao. 2004 Dec;39(12):1023-7. Yao Xue Xue Bao. 2004. PMID: 15813034 Chinese.

10

Pharmacodynamics and pharmacokinetics of the insulin-mimetic agent vanadyl acetylacetonate in non-diabetic and diabetic rats.

Zhang SQ, Zhong XY, Lu WL, Zheng L, Zhang X, Sun F, Fu GY, Zhang Q. Zhang SQ, et al. J Inorg Biochem. 2005 May;99(5):1064-75. doi: 10.1016/j.jinorgbio.2005.01.015. J Inorg Biochem. 2005. PMID: 15833329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,794 results

Search Page

Filters